MARC EGLAND: Open Payments
NPI 1902443831 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 49 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $214 |
| Amgen Inc. | 7 | $182 |
| Actelion Pharmaceuticals US, Inc. | 5 | $164 |
| Impulse Dynamics (USA) Inc. | 1 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| BridgeBio Pharma, Inc. | 3 | $117 |
| Merck Sharp & Dohme LLC | 5 | $114 |
| ABIOMED | 1 | $38 |
| Kestra Medical Technology Services, Inc. | 2 | $36 |
Products named: LifeVest, REPATHA, Optimizer, UPTRAVI, LEQVIO, Attruby, Kerendia, VERQUVO.
Industry payments across CO — which companies pay providers there.
